Recent Additions

Porcupine (synthetic DNA tagging system) by University of Washington
Biotech components: Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:51 (3 months ago)
Date last modified: 2020/12/18 14:51 (3 months ago)
Known funding amount: N/A
Funding types: University
Industry: Multipurpose + Novelty
Market status: Early Stage Concept
Organization type(s): University
Product categories: Other
Production process: N/A
Source: N/A
Trading symbol: N/A
Value chain stage: Input + Platform
Biotech components: Molecule
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (3 months ago)
Date last modified: 2020/12/18 14:40 (3 months ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Medical
Market status: Under Development
Organization type(s): Private Company
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Mast-MO (antibiotic wasp venom) by University of Pennsylvania’s Perelman School of Medicine
Biotech components: Animal + Bacteria + Molecule
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (3 months ago)
Date last modified: 2020/12/18 14:40 (3 months ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Virus
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (3 months ago)
Date last modified: 2020/12/18 14:40 (3 months ago)
Known funding amount: 28,500,000 USD
Funding types: Private Funding
Industry: Medical
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment + Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Virus
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (3 months ago)
Date last modified: 2020/12/18 14:39 (3 months ago)
Known funding amount: 50,000,000 USD
Funding types: Private Funding
Industry: Medical
Market status: Under Development
Organization type(s): Private Company
Product categories: Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Micro-algae fatty acids by Flinders University
Biotech components: Microbe
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (3 months ago)
Date last modified: 2020/12/18 14:39 (3 months ago)
Known funding amount: N/A
Funding types: University
Industry: Food & Agriculture + Health
Market status: Early Stage Concept
Organization type(s): University
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Bacterial toxin promoting tissue healing by Friedrich Schiller University Jena
Biotech components: Bacteria
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (3 months ago)
Date last modified: 2020/12/18 14:39 (3 months ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment + Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Biotech components: Molecule
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (3 months ago)
Date last modified: 2020/12/18 14:39 (3 months ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medicine + Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Endocannabinoids for intestinal infection treatment by University of Texas Southwestern Medical Center
Biotech components: Molecule + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (3 months ago)
Date last modified: 2020/12/18 14:39 (3 months ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Biotech components: Gene Editing + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:38 (3 months ago)
Date last modified: 2020/12/18 14:38 (3 months ago)
Known funding amount: N/A
Funding types: Private Funding + University
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input